الفهرس | Only 14 pages are availabe for public view |
Abstract Dalacin-C (clindamycin palmitate hydrochoride) is indicated in the treatment of serious infections due to sensitive anaerobic bacteria and gram- positive aerobic organisms. The aim of this study was to evaluate the teratogenic effects of Dalacin-C on pregnant rats and their fetuses. Pregnant albino rats (Rattus norvegicus) were administrated daily oral doses of 185 mg/kg of DALACIN-C from the 5th- 19th day of gestation. The animals were sacrificed at the 20th day of gestation. Fetuses were removed from the uterus and evaluated for mortality rate, growth parameters, morphological and skeletal malformation as well as histological study of liver, kidney and brain. Results showed significant reduction in weight gain of pregnant rats and decreased placental weight of pregnant rats treated with Dalacin-C. Fetal growth retardation during gestational period was recorded. Hematomas and anomalies of limbs were noticed morphologically in the recorded. These abnormalities included weak ossification of the skull bones roof. Histopathological studies of fetuses during gestation revealed Changes in liver histology such as degeneration of the cytoplasm of hepatocytes and increases in the number of megakaryocytes were seen, revealed degeneration in the tubular lining epithelium with swelling in the endothelial cells lining the tufts of the glomeruli within the Bowman’s capsule while in the brain tissue no histopathological alterations as recorded following Dalacin-C administration. Our findings suggest the need for great caution to handle Digoxin especially during pregnancy |